Literature DB >> 22466798

Elucidating the role of the phenylacetic acid metabolic complex in the pathogenic activity of Rhizoctonia solani anastomosis group 3.

Faith E Bartz1, Norman J Glassbrook, David A Danehower, Marc A Cubeta.   

Abstract

The soil fungus Rhizoctonia solani produces phytotoxic phenylacetic acid (PAA) and hydroxy (OH-) and methoxy (MeO-) derivatives of PAA. However, limited information is available on the specific role that these compounds play in the development of Rhizoctonia disease symptoms and concentration(s) required to induce a host response. Reports that PAA inhibits the growth of R. solani conflict with the established ability of the fungus to produce and metabolize PAA. Experiments were conducted to clarify the role of the PAA metabolic complex in Rhizoctonia disease. In this study the concentration of PAA and derivatives required to induce tomato root necrosis and stem canker, in the absence of the fungus, and the concentration that inhibits mycelial growth of R. solani were determined. The effect of exogenous PAA and derivatives of PAA on tomato seedling growth also was investigated. Growth of tomato seedlings in medium containing 0.1-7.5 mM PAA and derivatives induced necrosis of up to 85% of root system. Canker development resulted from injection of tomato seedling stems with 7.5 mM PAA, 3-OH-PAA, or 3-MeO-PAA. PAA in the growth medium reduced R. solani biomass, with 50% reduction observed at 7.5 mM. PAA, and derivatives were quantified from the culture medium of 14 isolates of R. solani belonging to three distinct anastomosis groups by GC-MS. The quantities ranged from below the limit of detection to 678 nM, below the concentrations experimentally determined to be phytotoxic. Correlation analyses revealed that isolates of R. solani that produced high PAA and derivatives in vitro also caused high mortality on tomato seedlings. The results of this investigation add to the body of evidence that the PAA metabolic complex is involved in Rhizoctonia disease development but do not indicate that production of these compounds is the primary or the only determinant of pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466798     DOI: 10.3852/11-084

Source DB:  PubMed          Journal:  Mycologia        ISSN: 0027-5514            Impact factor:   2.696


  6 in total

1.  Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia.

Authors:  Tasia Joy Lightly; Kara L Frejuk; Marie-Christine Groleau; Laurent R Chiarelli; Cor Ras; Silvia Buroni; Eric Déziel; John L Sorensen; Silvia T Cardona
Journal:  Appl Environ Microbiol       Date:  2019-11-27       Impact factor: 4.792

2.  UPLC-QTOF-MS metabolomics analysis revealed the contributions of metabolites to the pathogenesis of Rhizoctonia solani strain AG-1-IA.

Authors:  Wenjin Hu; Xinli Pan; Fengfeng Li; Wubei Dong
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 3.  Strategies to Manage Rice Sheath Blight: Lessons from Interactions between Rice and Rhizoctonia solani.

Authors:  Dayong Li; Shuai Li; Songhong Wei; Wenxian Sun
Journal:  Rice (N Y)       Date:  2021-02-25       Impact factor: 4.783

Review 4.  Progress in structural and functional study of the bacterial phenylacetic acid catabolic pathway, its role in pathogenicity and antibiotic resistance.

Authors:  Min Jiao; Wenbo He; Zhenlin Ouyang; Qindong Shi; Yurong Wen
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

5.  3-Methylthiopropionic Acid of Rhizoctonia solani AG-3 and Its Role in the Pathogenicity of the Fungus.

Authors:  Frederick Kankam; Hai-Tao Long; Jing He; Chun-Hong Zhang; Hui-Xiu Zhang; Lumei Pu; Huizhen Qiu
Journal:  Plant Pathol J       Date:  2016-04-01       Impact factor: 1.795

6.  Genes of the de novo and Salvage Biosynthesis Pathways of Vitamin B6 are Regulated under Oxidative Stress in the Plant Pathogen Rhizoctonia solani.

Authors:  Jamil Samsatly; Rony Chamoun; Emile Gluck-Thaler; Suha Jabaji
Journal:  Front Microbiol       Date:  2016-01-05       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.